Intensification with intermediate-dose intravenous methotrexate is effective therapy for children with lower-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group study
(Q73544184)
scientific article published on 01 March 2000
scientific article published on 01 March 2000
Language:
other details
description | scientific article published on 01 March 2000 |
External Links
(P356) |
10.1200/JCO.2000.18.6.1285
|
(P698) |
10715299
|